Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?

Current Opinion in Cardiology

Volumn 25, Issue 1, 2010, Pages 23-28

  Amin, Mitesh S ^a   Ellenbogen, Kenneth A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Advisory; Device malfunction; Implantable cardioverter defibrillator; Lead fracture; Recall

Indexed keywords

CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE REMOVAL; EMOTIONAL STRESS; EQUIPMENT; EQUIPMENT DESIGN; FOOD AND DRUG ADMINISTRATION; GENERATOR; HEART VENTRICLE ARRHYTHMIA; HUMAN; MEDICAL DECISION MAKING; PACEMAKER FAILURE; PATIENT COUNSELING; PATIENT REFERRAL; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RELIABILITY; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS; RISK ASSESSMENT;

EID: 74249096367     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328333d375     Document Type: Review

References (25)

1. Carlson MD, Wilkoff BL, Maisel WH, et al. Recommendations from the Heart Rhythm Society task force on device performance policies and guidelines. Heart Rhythm 2006; 3:1250-1273.
2. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA 2005; 294:955- 958; 5.
3. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 2006; 295:1901-1906.
4. Maisel WH, Sweeney MO, Stevenson WG, et al. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 2001; 286:793-799.
5. Myerburg RJ, Feigal DW, Lindsay BD. Life-threatening malfunction of implantable cardiac devices. N Engl J Med 2006; 354:2309-2311.
6. Maisel WH. Physician management of pacemaker and implantable cardioverter- defibrillator advisories. Pacing Clin Electrophysiol 2004; 27:437-442.
7. Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999; 100:2344- 2352; 12.
8. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 2006; 295:1929-1934.
9. Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter- defibrillator follow-up: a status report. Pacing Clin Electrophysiol 2005; 28:235-240.
10. Varma N. Remote monitoring for advisories: automatic early detection of silent lead failure. Pacing Clin Electrophysiol 2009; 32:525-527.
11. Gould PA, Krahn AD, Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverterdefibrillator replacement in response to device advisories. JAMA 2006; 295:1907-1911.
12. Gould PA, Gula LJ, Champagne J, et al. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm 2008; 5:1675-1681.
13. Kapa S, Hyberger L, Rea RF, Hayes DL. Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 2007; 30:730-733.
14. Costea A, Rardon DP, Padanilam BJ, et al. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008; 19:266-269.
15. Amin MS, Matchar DB, Wood MA, Ellenbogen KA. Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. JAMA 2006; 296:412-420.
16. Gula LJ, Massel D, Krahn AD, et al. Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls: adding statistical insight to clinical intuition. Am Heart J 2007; 153:253-259.
17. Priori SG, Auricchio A, Nisam S, Yong P. To replace or not to replace: a systematic approach to respond to device advisories. J Cardiovasc Electrophysiol 2009; 20:164-170.
18. Amin MS, Wood MA, Shepard RK, et al. Clinical judgment versus decision analysis for managing device advisories. Pacing Clin Electrophysiol 2008; 31:1236-1240.
19. Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study, an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol (in press).
20. Amin MS, Fox AD, KalahastyG, et al. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 2008; 19:1275-1280.
21. Chan PS, Nallamothu BK, Spertus JA, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009; 2:16-24.
22. Sanders GD, Kong M, Al-Khatib SN, Peterson ED. Cost-effectiveness of the implantable cardioverter defibrillator in the elderly. Circulation 2008; 118:S1118.
23. Groeneveld PW, Farmer SA, Suh JJ, et al. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008; 5:646-653.
24. Birnie DH, Sears SF, Green MS, et al. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience. Europace 2009; 11:26-30.
25. Gibson DP, Kuntz KK, Levenson JL, Ellenbogen KA. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace 2008; 10:540-544.